|Day Low/High||221.50 / 227.56|
|52 Wk Low/High||208.07 / 287.94|
Healthcare stocks lagged Friday following the President's actions against Obamacare.
Events that would normally give investors pause have merely primed the pump.
Teva could be on the verge of a surge similar to what 3 other companies have seen since 2008-09.
Hear me out: The same lessons and disciplines are useful in both.
UNH continues to rise, and we have a new price target and stop level.
Let's see if the upward moves of these 10 stocks are merited.
It's difficult for even the best companies to resist infection.
A slide in Goldman Sachs and UnitedHealth shares pull the Dow lower by nearly triple digits.
TheStreet's Action Alerts PLUS Portfolio Manager Jim Cramer weighs in on Tuesday's trending stocks.
Cramer is fond of UnitedHealth's latest quarter.
It's Report Week: Keep an Eye on the Big Companies
Senate leader Mitch McConnell says he will kill the healthcare bill after two more Senators said they would vote against it.
Bulletproof coffee in hand, a quick scan of the markets shows the futures up ever so slightly as investors grapple with the realization the GOP is giving up on replacing the Affordable Care Act and is turning to repealing it. That news is pressuring...
What to expect from United Continental, UnitedHealth and Lockheed Martin's earnings.
As always, it was good seeing everyone on the Daily Diary sitting in for Doug Kass. Lots of good conversation despite a quiet day in the market with the market indices ending the day pretty much where they started. Very narrow range of trading throu...
Procter & Gamble proxy fight is an intriguing distraction.
Changes in economy have shored up weak areas.
Here comes some volatility in the markets.
The Senate just unveiled more details about its health care reform bill.
We forget that a big hedge fund or mutual fund switching out of tech winners into everything else can roil the market.
From price momentum to signs of irrational exuberance, several things have me worried.
These three stocks are showing short-term gain catalysts and longer-term growth potential.
It's a wonder to me how split this market really is.